Keyphrases
Plasma Fatty Acids
58%
Phospholipid Fatty Acid Profiles
58%
Urinary Albumin Concentration
58%
Desaturase
58%
Incident Hypertension
58%
Metabolic Syndrome
58%
End-organ Disease
58%
Fatty Acid Profile
40%
Hypertension
38%
Plasma Phospholipids
29%
Plasma Triglycerides
29%
Hazard Ratio
19%
Plasma Fatty Acid Profile
14%
Fatty Acid Desaturase
11%
Triglycerides
11%
Phospholipids
11%
Metabolic Syndrome Prevalence
11%
Fatty Acid Intake
11%
Confidence Interval
9%
Potential Confounders
9%
Premature Death
9%
Risk Factors for Cardiovascular Diseases
9%
Kidney Disease
9%
Path Analysis
9%
Population-based
9%
Hypertension Risk
9%
Causal Pathways
9%
Sodium Intake
9%
Creatine Kinase
9%
Protein Intake
9%
Gender Analysis
9%
Antihypertensive Drugs
9%
Major Risk Factors
9%
NMR Spectroscopy
9%
High Concentration
9%
Confounder Correction
8%
Lignoceric Acid
7%
Behenic Acid
7%
Stearoyl-CoA Desaturase 1 (SCD1)
5%
Logistic Regression
5%
Essential Fatty Acids
5%
New Characteristics
5%
Odds Ratio
5%
Saturated Fatty Acids
5%
Precursor Ratio
5%
Moderation Effect
5%
International Diabetes Federation
5%
Netherlands
5%
Baseline Characteristics
5%
Metabolic Disease
5%
Biochemistry, Genetics and Molecular Biology
Phospholipid Blood Level
100%
Prevalence
75%
Fatty Acid Blood Level
70%
Triglyceride
58%
Population
58%
Cross Sectional Study
58%
Creatine Kinase
58%
Magnetism
58%
Precursor
31%
Stearoyl-CoA
19%
Cohort Study
19%
Phospholipid
16%
Lipogenesis
11%
Very Long Chain Fatty Acid
11%
Essential Fatty Acid
8%
Metabolic Disorder
8%
Saturated Fatty Acid
8%
Medicine and Dentistry
Kidney Graft
58%
Saturated Fatty Acid
58%
Infection
36%
Immunocompromised Patient
14%
Lignoceric Acid
7%
Behenic Acid
7%
Flame Ionization Detector
7%
All Cause Mortality
7%
Phagocytosis
7%
Arachidonic Acid
7%
Gas Chromatography
7%
Proportional Hazards Model
7%
Immunosuppressive Treatment
7%
Outpatient
7%
Prospective Cohort Study
7%
High Density Lipoprotein Cholesterol
7%